Core Viewpoint - Oscar Health's CEO Mark Bertolini asserts that 2026 will be the year the company achieves profitability, driven by AI efficiency, significant rate increases, and market share growth as competitors exit the ACA exchange market [1] Financial Performance - Oscar Health reported a Q4 EPS of -$1.24, missing the estimate of -$0.92 by nearly 35% [1] - The medical loss ratio (MLR) for Q4 was 95.4%, an increase from 88.1% the previous year, indicating high medical costs relative to premiums collected [1] - The company anticipates a $750 million improvement in earnings from operations in 2026, targeting earnings of $250 million to $450 million compared to a loss of $396 million in 2025 [1] Strategic Initiatives - **AI-Driven Efficiency**: The introduction of an AI bot for care guides has reduced response times by 67% during peak enrollment periods, and the health agent "Oswell" answers 86% of member questions accurately [1] - **Pricing Discipline**: Oscar implemented a weighted average rate increase of approximately 28% for 2026, accounting for the expiration of enhanced premium tax credits that inflated enrollment with higher-risk members in 2025 [1] - **Membership Growth**: As of February 1, 2026, Oscar enrolled 3.4 million members, a significant increase from previous years, which helps spread fixed costs [1] Market Context - Oscar's market share increased from 17% in 2025 to 30% in 2026, aided by CVS Health's exit from the individual ACA exchange market [1] - The company has $2.77 billion in cash and a new $475 million revolving credit facility, providing a financial runway to execute its profitability strategy [1]

Core Viewpoint - Oscar Health's CEO Mark Bertolini maintains that the company will achieve profitability by 2026, despite disappointing Q4 2025 results [2][4]. Financial Performance - In Q4 2025, Oscar Health reported an EPS of -$1.24, missing the estimate of -$0.92 by nearly 35% [3]. - The medical loss ratio (MLR) for Q4 was 95.4%, up from 88.1% the previous year, indicating that Oscar spent 95 cents on medical costs for every dollar of premium collected [3]. - Despite the poor financial results, Oscar's stock rose approximately 9.6% following the Q4 announcement, as investors focused on future profitability [3][8]. 2026 Profitability Guidance - Oscar Health anticipates a significant year-over-year improvement of nearly $750 million in earnings from operations in 2026, targeting earnings from operations of $250 million to $450 million, compared to a loss of $396 million in 2025 [4][8]. - The company aims to reduce the MLR to between 82.4% and 83.4% in 2026, a substantial improvement from Q4's 95.4% [5][8]. Strategic Initiatives - **Lever One: AI-driven Efficiency** Oscar is implementing AI technologies to enhance operational efficiency, with the Agentic AI bot reducing response times by 67% during peak enrollment periods and achieving high accuracy in addressing member inquiries [6]. - **Lever Two: Pricing Discipline** The company has taken a weighted average rate increase of approximately 28% for 2026, accounting for the expiration of enhanced premium tax credits that inflated enrollment with higher-risk members in 2025 [7]. - **Lever Three: Market Share Gains** Oscar Health is positioned to gain market share as CVS Health exits the ACA exchange market, which may provide additional opportunities for growth [8].